Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Dendritic Cells in Recurrent Bladder Cancer
NCT04184232Phase 2Completed
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TLP0-001 in bladder cancer. Started Jul 2019; status: completed.
02
Drugs
TLP0-001
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT04184232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04184232.